Best Managed Healthcare Companies To Watch For 2014

For three decades or so, Saudi Arabia has wielded considerable influence on the global oil market. The kingdom's status as the world's only "swing producer" has given it the unparalleled ability to influence oil prices by boosting or reducing its production and exports, which it has done at various times over the past few decades.

Indeed, Saudi Arabia may be the only major oil-producing nation in the world with the ability to influence the global price of oil to a noticeable degree. But now, it appears that the Saudis are gradually losing their powerful grip on the world oil market.

Why Saudi influence could diminish
There are at least two major reasons why we could see Saudi Arabia's influence on oil prices wane over coming years. The first is expected growth in non-OPEC oil supplies, mainly from North American shale and oil sands production, while the second is changing oil consumption patterns among the Saudis themselves.

This year, non-OPEC supplies are expected to increase by nearly 1 million barrels a day, led mainly by production growth from U.S. shale plays like North Dakota's Bakken and Texas' Eagle Ford. Over the past few years, these plays have experienced tremendous growth, as new and improved drilling techniques have allowed operators to coax massive quantities of oil and gas from the ground.

Top 5 Forestry Stocks To Watch For 2015: Inovio Pharmaceuticals Inc (INO)

Inovio Pharmaceuticals, Inc., incorporated on June 29, 1983, is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV). The Company's electroporation delivery technology uses brief, controlled electrical pulses to increase cellular uptake of the vaccine. Its clinical programs include cervical dysplasia (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), hepatitis C virus (HCV) and HIV vaccines. It is advancing preclinical research and clinical development for a universal seasonal/pandemic influenza vaccine, as well as preclinical work for other products, including malaria and prostate cancer vaccines. Its partners and collaborators include University of Pennsylvania, Drexel University, National Microbiology Laboratory of the Public Health Agency of Canada, Program for Appropriate Technology in Health/Malaria Vaccine Initiative (PATH/MVI), National Institute of Allergy and Infectious Diseases (NIAID), Merck, ChronTech, University of Southampton, United States Military HIV Research Program (USMHRP), the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and HIV Vaccines Trial Network (HVTN). As of December 31, 2011 it owned 16.1% interest in VGX Int��.

Inovio�� Solution

The Company�� synthetic vaccine platform consists of its SynCon vaccine design process and electroporation delivery technology. It has developed a preclinical and clinical stage pipeline of vaccines. The Company�� synthetic vaccines are designed to prevent a disease (prophylactic vaccines) or treat an existing disease (therapeutic vaccines). Its synthetic vaccine consists of a deoxyribonucleic acid (DNA) plasmid encoding a selected antigen! (s), which is introduced into cells of humans or animals with the purpose of evoking an immune response to the encoded antigen. The Company�� synthetic vaccines are designed to generate specific antibody and/or T-cell responses.

The Company�� SynCon technology provides processes that employ bioinformatics, which combine extensive genetic data and sophisticated algorithms. Its design process uses the genetic make-up of a common antigen(s) from multiple strains of a virus within a viral sub-type or taxonomic group (family) of pathogens, such as HIV, hepatitis C virus (HCV), human papillomavirus (HPV), influenza and other diseases to synthetically create a new antigen for the desired pathogen target that does not exist in nature. Its synthetic vaccine candidates are being delivered into cells of the body using its electroporation (EP) DNA delivery technology.

Cancer Synthetic Vaccines

The Company has two broad types of cancer vaccines: preventive (or prophylactic) vaccines, which are intended to prevent cancer from developing in healthy people, and treatment (or therapeutic) vaccines, which are intended to treat an existing cancer by strengthening the body�� natural defenses against the cancer. Two types of cancer preventive vaccines are available in the United States. The United States Food and Drug Administration (the FDA) has approved two vaccines, Gardasil and Cervarix that protect against infection by the two types of HPV-types 16 and 18-that cause approximately 70% of all cases of cervical cancer worldwide. In addition, Gardasil protects against infection by two additional HPV types, 6 and 11, which are responsible for about 90% of all cases of genital warts in males and females but do not cause cervical cancer.

Cervarix manufactured by GlaxoSmithKline, is composed of virus-like particles (VLPs) made with proteins from HPV types 16 and 18. Cervarix is approved for use in females��ages 10 to 25 for the prevention of cervical cancer caused by! HPV type! s 16 and 18. Gardasil manufactured by Merck, is approved for use in females for the prevention of cervical cancer, and some vulvar and vaginal cancers, caused by HPV types 16 and 18 and for use in males and females for the prevention of genital warts caused by HPV types 6 and 11. The vaccine is approved for these uses in females and males ages 9 to 26. The FDA has also approved a cancer preventive vaccine that protects against hepatitis B virus (HBV) infection.

Inovio�� VGX-3100 is designed to raise immune responses against the E6 and E7 genes of HPV types 16 and 18 that are present in both pre-cancerous and cancerous cells transformed by these HPV types. E6 and E7 are oncogenes that play an integral role in transforming HPV-infected cells into cancerous cells. In March 2011, it initiated a randomized, double-blind Phase II study of VGX-3100 delivered using the CELLECTRA intramuscular electroporation device in women with HPV Type 16 or 18 and diagnosed with, but not yet treated for, cervical intraepithelial neoplasia (CIN) 2/3. The study is designed to enroll 148 subjects. In January 2011, it announced the publication of a scientific paper in the journal Human Vaccines detailing potent immune responses in a preclinical study of its SynCon vaccine for prostate cancer targeting two antigens, prostate specific antigen (PSA) and prostate specific membrane antigen (PSMA).

In January 2011, the Company announced the regulatory approval of a Phase II clinical trial (WIN Trial) to treat leukemia utilizing its new ELGEN 1000 automated vaccine delivery device. The single dose level, Phase II study, called WT1 immunity via DNA fusion gene vaccination in haematological malignancies by intramuscular injection followed by intramuscular electroporation. Cancer Vaccines encodes for hTERT, an antigen related to non-small cell lung, breast and prostate cancers. The vaccine is delivered using its electroporation delivery technology.

Infectious Disease Synthetic Vaccines

In Marc! h 2011, the Company announced the initiation of a follow-on open label, single dose Phase II clinical study in collaboration with ChronTech of the ChronVac-C HCV DNA vaccine delivered using its electroporation technology in treatment naive HCV infected individuals. Its HIV vaccines consist of candidates for HIV prevention, as well as therapy or treatment. PENNVAX-B is designed to target HIV clade B (most commonly found in the United States, North America, Australia and the European Union (EU). PENNVAX-G is designed to target HIV clades A, C and D, which are more commonly found in Asia, Africa, Russia and South America. This Phase I clinical study of PENNVAX-B (HVTN-080) vaccinated 48 healthy, HIV-negative volunteers to assess safety and levels of immune responses generated by Inovio�� PENNVAX-B vaccine delivered with its CELLECTRA electroporation device. PENNVAX-B is a SynCon vaccine that targets HIV gag, pol, and env proteins.

The Company�� VGX-3400X targets H5N1. The vaccine consists of three distinct DNA plasmids coded for a consensus hemagglutinin (HA) antigen derived from different H5N1 virus strains; a consensus neuraminidase (NA) antigen derived from different N1 sequences; and a consensus nucleoprotein (NP) fused to a small portion of the m2 protein (m2E) based on a broader cross-section of influenza viruses in addition to H5N1 and H1N1. Conventional vaccines are strain-specific and have limited ability to protect against genetic shifts in the influenza strains they target. They are therefore modified annually in anticipation of the next flu season�� new strain(s). It is focused on developing DNA-based influenza vaccines able to provide broad protection against known as well as newly emerging, unknown seasonal and pandemic influenza strains.

Animal Health/Veterinary

VGX Animal Health, Inc. (VGX AH), a majority-owned subsidiary, has licensed LifeTide, a plasmid-based growth hormone releasing hormone (GHRH) technology for swine. LifeTide is one of onl! y four DN! A-based treatments approved for use in animals and is the only DNA-based agent delivered using electroporation that has been granted marketing approval (Australia). VGX AH is also developing a GHRH-based treatment for cancer and anemia in dogs and cats. It is developing a synthetic vaccine for foot-and-mouth disease (FMD) administered by its vaccine delivery technology. The FMD virus is one of the most infectious diseases affecting farm animals, including cattle, swine, sheep and goats, and is a serious threat to global food safety.

The Company competes with Crucell N.V, Sanofi-Aventis, Novartis, Inc., GlaxoSmithKline plc, Merck, Pfizer, AstraZeneca, Inc., Novartis, Inc., MedImmune and CSL.

Advisors' Opinion:

• [By MONEYMORNING]

  Inovio Zooms: We recommended biotech Inovio Inc. (NYSE: INO) at 71 cents a share back on Feb. 1, 2013, and have re-recommended it a number of times since. With their 15.2% gain yesterday, the shares are now at $3.71, up 414% from where we first told you about them - and we believe there's more to come. In fact, we'll be bringing you an interesting update on this company very soon. Inovio is one of 24 recommendations that have doubled or better since we launched Private Briefing back in August 2011.

Best Managed Healthcare Companies To Watch For 2014: Industrias CH SAB de CV (ICHB)

Industrias CH SAB de CV (ICH) is a Mexico-based holding company engaged, together with its subsidiaries, in the steel industry. The Company's activities include the production, processing and distribution of special bar quality (SBQ) steel products; coated and uncoated seamed pipes; structural steel products, such as beams, channels, flat bars and angles; light structurals, such as angles, flat and merchant bars; as well as reinforced and corrugated steel bars. The Company�� facilities include production and processing plants in Mexico, the United States and Canada. Advisors' Opinion:

• [By Julia Leite]

  The IPC rose 2.5 percent to 40,623.30 at the close in Mexico City. The index gained 6.8 percent on the week, the most since July 2009. Steelmaker Industrias CH SAB (ICHB) was the biggest gainer today, while homebuilders Desarrolladora Homex SAB, Urbi Desarrollos Urbanos SAB, and Corp. Geo SAB were the week�� best performers.

Best Managed Healthcare Companies To Watch For 2014: Vornado Realty Trust(VNO)

Vornado Realty Trust is a privately owned real estate investment trust. The trust engages in investment, ownership, and management of commercial real estate. It invests in the real estate markets of United States. The trust primarily invests in office, industrial and retail properties. Vornado Realty Trust is based in New York, New York.

Advisors' Opinion:

• [By Anna Prior]

  Vornado Realty Trust sa(VNO)id its board of trustees has approved a plan to spin off the commercial property owner’s shopping center business into a new publicly traded real-estate investment trust.

• [By Robert Hsu]
  Name Type of Security� Recommendation� Kinder Morgan Energy Partners L.P. (NYSE: KMP) � MLP August 15, 2013� TeeKay LNG Partners L.P.� (NYSE: TGP) � MLP September 16, 2013� PowerShares S&P 500 BuyWrite Portfol ETF� (NYSE Arca: PBP)� Buy-Write ETF September 30, 2013� Madison Covered Call Equity Strtgy Fd (NYSE: MCN)� Buy-Write ETF September 30, 2013� Nuveen Equity Premium Opportunity Fund (NYSE: JSN)� Buy-Write ETF September 30, 2013� BlackRockEnhanced Dividend Achievers Tr (NYSE: BDJ)� Buy-Write ETF September 30, 2013� Vornado Realty Trust � (NYSE: VNO)� Real Estate
  Investment
  Trust September 26, 2013�
  
  

  Robert Hsu is the editor of Permanent Wealth Investor and a former hedge fund portfolio manager at Wall Street powerhouse Goldman Sachs. He retired from Goldman at age 31. He since has come out of retirement to establish and preside over his money management firm, Absolute Return Capital Advisors. His retirement experience has given him his current mission: helping investors like you achieve their goal of comfortable retirement through profitable income strategies.

• [By Robert Hsu]

  Vornado Realty Trust (NYSE: VNO) is a traditional REIT.

  Unlike mortgage REITs, Vornado actually invests directly in prime real estate properties such as office buildings, and the rents from these properties are what Vornado uses to generate income for unitholders.

Best Managed Healthcare Companies To Watch For 2014: JPMorgan Chase & Co (AMJ)

JPMorgan Chase & Co. (JPMorgan Chase), incorporated on October 28, 1968, is a financial holding company. The Company is a global financial services firm and a banking institution in the United States, with global operations. The Company is engaged in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, asset management and private equity. JPMorgan Chase�� principal bank subsidiaries are JPMorgan Chase Bank, National Association (JPMorgan Chase Bank, N.A.), a national bank with the United States branches in 23 states, and Chase Bank USA, National Association (Chase Bank USA, N.A.), a national bank that is the Company�� credit card-issuing bank. JPMorgan Chase�� non-bank subsidiary is J.P. Morgan Securities LLC (JPMorgan Securities), the Company�� the United States investment banking firm. The bank and non-bank subsidiaries of JPMorgan Chase operate nationally, as well as through overseas branches and subsidiaries, representative offices and subsidiary foreign banks. One of the Company�� principal operating subsidiaries in the United Kingdom is J.P. Morgan Securities plc., a subsidiary of JPMorgan Chase Bank, N.A. JPMorgan Chase�� activities are organized into four business segments, as well as Corporate/Private Equity. The Company�� consumer business is the Consumer & Community Banking segment. The Company�� wholesale businesses consists of Corporate & Investment Bank, Commercial Banking, and Asset Management segments. Effective January 7, 2014, JPMorgan Chase & Co acquired an undisclosed minority stake in Chi-X Global Holdings LLC.

Consumer & Community Banking

Consumer & Community Banking (CCB) serves consumers and businesses through personal service at bank branches and through automated teller machines (ATMs), online mobile and telephone banking.CCB is organized into Consumer & Business banking, Mortgage Banking (including Mortgage Production and Servicing, and Real Estate Portfolios! ) and Card, Merchant Services & Auto (Card). Consumer & Business Banking offers deposit and investment products and services to consumers, and lending, deposit, and cash management and payment solutions to small businesses. Mortgage Banking includes mortgage origination and servicing activities, as well as portfolios comprised of residential mortgages and home equity loans, including the purchased credit impaired (PCI) portfolio acquired in the Washington Mutual transaction. Mortgage origination channels consists of Retail, Wholesale, Correspondent and Correspondent negotiated transactions. Retail includes Borrowers who buy or refinance a home through direct contact with a mortgage banker employed by the Firm using a branch office, the Internet or by phone. Wholesale refers to third-party mortgage brokers loan application packages to the Company. The Company then underwrites and funds the loan. Correspondent includes Banks, thrifts, other mortgage banks and other financial institutions that sell closed loans to the Firm. Correspondent negotiated transactions include mid-to-large-sized mortgage lenders, banks and bank-owned mortgage companies sell servicing to the Firm on an as-originated basis (excluding sales of bulk servicing transactions). Card issues credit cards to consumers and small businesses, provides payment services to corporate and public sector clients through its commercial card products, offers payment processing services to merchants, and provides auto and student loan services.

Corporate & Investment Bank

The Corporate & Investment Bank (CIB) offers a suite of investment banking, market-making, prime brokerage, and treasury and securities products and services to a global client base of corporations, investors, financial institutions, government and municipal entities. Within Banking, the CIB offers a range of investment banking products and services in all major capital markets, including advising on corporate strategy and structure, capital-raising in equity ! and debt ! markets, as well as loan origination and syndication. The Company also provides Treasury Services, which includes transaction services, comprised primarily of cash management and liquidity solutions, and trade finance products. The Markets & Investor Services segment of the CIB is engaged in cash securities and derivative instruments, and also offers risk management solutions, prime brokerage, and research. Markets & Investor Services also includes the Securities Services business, which holds, values, clears and services securities, cash and alternative investments for investors and broker-dealers, and manages depositary receipt programs globally.

Commercial Banking

Commercial Banking (CB) provides industry knowledge, and service to the United States multinational clients, including corporations, municipalities, financial institutions and non-profit entities with annual revenue generally ranging from $20 million to $2 billion. CB provides financing to real estate investors and owners. CB also provides financial solutions, including lending, treasury services, investment banking and asset management to meet its clients��domestic and international financial needs. Commercial Banking is divided into four client segments: Middle Market Banking, Commercial Term Lending, Corporate Client Banking, and Real Estate Banking. Middle Market Banking covers corporate, municipal, financial institution and not-for-profit clients. Commercial Term Lending provides term financing to real estate investors/owners for multifamily properties, as well as financing office, retail and industrial properties. Real Estate Banking provides full-service banking to investors and developers of institutional-grade real estate properties. Lending and investment activity within the Community Development Banking and Chase Capital segments are included in other.

Asset Management

Asset Management (AM) clients include institutions, high-net-worth individuals and retail investors. AM offe! rs invest! ment management across all major asset classes including equities, fixed income, alternatives and money market funds. AM also offers multi-asset investment management, providing solutions to a broad range of clients��investment needs. For individual investors, AM also provides retirement products and services, brokerage and banking services including trust and estate, loans, mortgages and deposits. The majority of AM�� client assets are in actively managed portfolios. AM�� client segments consists of Private Banking, Institutional and Retail. Private Banking offers investment advice and wealth management services to high- and ultra-high-net-worth individuals, families, money managers, business owners and small corporations worldwide, including investment management, capital markets and risk management, tax and estate planning, banking, capital raising and specialty-wealth advisory services. Institutional brings comprehensive global investment services including asset management, pension analytics, asset-liability management and active risk-budgeting strategies to corporate and public institutions.

Advisors' Opinion:

• [By Robert Rapier]

  The biggest problem with the fund is that while it yields an attractive 7.5 percent annually based on the most recent quarterly distribution, the total expense ratio is presently an astronomical 4.4 percent. This is bound to be a drag on performance over the long run (although it still potentially offers an attractive short-term play). As a result, my preference for a long term investment in and IRA would be to own an exchange-traded note (ETN) based on one of the Alerian indices that I reviewed recently in Navigating the Universe of MLPs. There are several to choose from, including the JPMorgan Alerian MLP Index ETN (NYSE: AMJ), which presently yields 5 percent and has an expense ratio of 0.85 percent.

Best Managed Healthcare Companies To Watch For 2014: UnipolSai Assicurazioni SpA (US)

UnipolSai Assicurazioni SpA, formerly Fondiaria SPA, is an Italy- based company engaged in financial sector. The Company is a result of the merger of Unipol Assicurazioni SpA, Milano Assicurazioni SpA and Premafin Finanziaria SpA into Fondiaria Sai SpA. The Company operates through approximately 3 000 agencies under brands, such as Unipol, Sai, La Fondaria, Milano, La Previdente, Nuova Maa and Sasa. UnipolSai Assicurazioni SpA specializes in non-life insurance, especially automobile insurance. Additionally, UnipolSai Assicurazioni SpA provides products which protect its clients against damage and accident in the field, such as work, home, travel, health, life, aviation, railway, fire, maritime and goods in transit, as well as reinsurance and legal protection. Advisors' Opinion:

• [By John Heinzl]

  Consider Netflix (NFLX), the video-streaming company whose stock has risen more than five-fold in the past year, and which closed Friday at $328.03 (US). The most pessimistic analyst on Wall Street has a 12-month target of $72; the most optimistic has a target of $460. Such wide dispersion indicates that analysts don't really know how to value the company; there are too many variables at play.

• [By Chris Umiastowski]

  Almost one year ago, I added the online travel giant Priceline.com, Inc. (PCLN) to my Strategy Lab portfolio. At the time, the stock had already been a star performer in the S&P 500 (SPX) for several years, and I bought my shares at about $627 (US) each.

Best Managed Healthcare Companies To Watch For 2014: Mitek Systems Inc (MITK)

Mitek Systems, Inc. (Mitek), incorporated in 1986, is engaged in the development, sale and service of software solutions related to mobile imaging applications and intelligent recognition software. Mitek is applying its technology and in image correction, optical character recognition and intelligent data extraction to mobile devices. Using Mitek Mobile Apps, camera-equipped smartphone users can deposit checks, pay bills, save receipts and fax documents. Users simply take a picture of the document and its products corrects image distortion, extracting relevant data, routing images to their desired location, and processing transactions through users��financial institutions. It has developed and deployed Mobile Deposit, a software application that allows users to deposit a check using their smartphone camera. It has developed and deployed Mobile Receipt, a receipt archival and expense report application, and Mobile Phax, a mobile document faxing application. Its Mobile Photo Bill Pay, a mobile bill paying application that allows users to pay their bills using their smartphone camera. During fiscal year ended September 30, 2010 (fiscal 2010), it had one operating segment based on its product and service offerings.

IMagePROVE Technology Products

Using IMagePROVE, the Company has a suite of business productivity applications for camera-equipped smartphones, including the iPhone and selected BlackBerry, Android and Windows Mobile handsets. It has four products that use its IMagePROVE technology Mobile Deposit, Mobile Receipt, Mobile Phax and Mobile Photo Bill Pay. Its products are used in the financial services industry. It has secured sales partnerships with system integrators for the financial services industry, including Fiserv, FIS, NCR, Jack Henry, Wausau, BankServ, RDM, J&B Software and Bluepoint Solutions.

The Company�� Mobile Deposit is the smartphone application allows banks to accept check deposits through photos of checks taken with camera-equipped smart! phones. Mobile Deposit allows users to make deposits by photographing the front and back of a check and submitting the item electronically to their bank from their smartphone. Its Mobile Receipt is designed to convert the photo of a receipt taken with a smartphone into an image and with a single touch, converts the data into a professional looking expense report. Mobile Phax allows user to take a photo of any letter sized document or page and send it as a portable document format (PDF) file to any e-mail address or fax machine.

The Company�� Mobile Photo Bill Pay allows users to take pictures of their bills with their smartphone cameras and its Mobile Photo Bill Pay product correct image distortion, reading relevant data and processing the transactions through the users��banks. The payment is made electronically by debiting the users checking account and using existing online bill pay systems. With Mobile Photo Bill Pay, users can submit electronic payments from their smartphones without having to write checks, lick stamps, visit a payment location or even use their personal computers.

ImageNet Intelligent Character Recognition Toolkits

The Company�� ImageNet products are designed to provide remittance processing, proof of deposit and lock box processing applications. Its products are used to reduce manual labor by automatically extracting amounts and routing information from checks and distinguishing between common document types, such as personal and business checks, substitute checks, pre-authorized drafts and other document types specified by customers. It sells ImageNet suite of products to its channel partners, who resell them as integrated components of their solutions and services. Its ImageNet suite of products includes ImageNet Prep & ID, ImageNet Payments, ImageNet Data Capture and ImageNet Signatures.

ImageNet Prep & ID is a software toolkit that is designed to provide automatic form information document (ID), form registration and fo! rm/templa! te removal. Image Net Prep & ID reduces the image size by removing information, such as pre-printed text, lines, and boxes; leaving only the filled-in data. ImageNet Payments allows for the automatic reading of machine and hand print information found on scanned documents and forms from any structured form, as well as bank documents, such as checks, deposit slips, and remittance coupons. ImageNet Payments integrates technology components from the CheckReader product that it licenses from a vendor that is designed to read rates of the currency and legal amounts of checks drawn on the United States and Canadian financial institutions.

ImageNet Data Capture is a software toolkit that captures data from types of unstructured business documents. ImageNet Data Capture is used in data capture applications where data must be found and extracted from documents that have no pre-determined format or layout, but share common data elements. ImageNet Data Capture is designed to locate this data on documents using contextual, positional, format and keyword specific information. It has supplied ImageNet Data Capture as a stand alone application programming interface (API) to several original equipment manufacturers (OEMs) in the document processing field. ImageNet Signatures is a software toolkit that locates, extracts and verifies signatures in any document. It encodes each signature and compares it with encoded reference examples rather than comparing actual images. Its image analytics encode 60 characteristics of each signature, which allows for accurate signature fraud detection.

FraudProtect Systems

The Company�� FraudProtect System is an automated software application designed to allow banks to detect check fraud from forged signatures and counterfeit checks, as well as the detection of pre-authorized drafts and payee name alterations. Its FraudProtect suite of products includes FraudProtect SDK, PADsafe and PayeeFind. Its FraudProtect SDK is a toolkit designed to detect c! heck frau! d and forgery using image analytics to uncover inconsistencies and alterations in checks as they are processed by banks. These products are sold to OEMs and system integrators and can detect forged or illegally modified checks. Its PADsafe product detects fraudulent preauthorized drafts (PADs). PADsafe automatically identifies PADs from checks, and then notifies the user of fraudulent transactions, reducing and preventing the unauthorized withdrawal of funds. Its PayeeFind product is designed to prevent payee-altered checks from clearing.

ImageScore

ImageScore is the Company�� Check 21 readiness solution for any financial institution that truncates or uses check images in an accounts receivables conversion environment. Integrated solution providers for financial institutions can also buy ImageScore to enhance their products. ImageScore is designed to analyze check images to provide the usability and information needed to help financial institutions act in accordance with regulatory and industry mandates.

Advisors' Opinion:

• [By Eric Volkman]

  Mitek Systems (NASDAQ: MITK  ) is hoping to widen its capital base. The company announced it is floating nearly 2.86 million shares of its common stock in an underwritten public flotation, at a price of $5.25 per share. Additionally, the company's underwriters have been granted a 30-day option to purchase up to 428,571 shares to cover overallotments, if any.

• [By U.S. News]

  In at least one Texas bank and one Ohio credit union, 3D video banking is currently undergoing testing, according to TheFinancialBrand.com, a website for bank and credit union marketing executives. Three-dimensional video banking is similar to a consumer video conference with a bank representative –- only in this case, the executive looks like a living, breathing person sitting across from you. Thanks to theater surround sound, the representative also sounds as if they're in the same room. And since the consumer is interacting with a real person and not an automated hologram, the experience apparently isn't much different than the real thing. Banking and managing money isn't what it used to be. The 1970s and 1980s brought us the rise of the ATM. Consumers became acquainted with online banking during the 1990s and the first decade of the 2000s. The 2010s are shaping up as the era of mobile banking. That was underscored Sept. 10-11 in New York City when Mitek Systems Inc. (MITK), a San Diego-based technology company, debuted its Mobile Photo Account Opening product at Finovate, a trade show where banking tech products are often unveiled. The product allows consumers to open a bank account within 60 seconds. If you have your bank's app, you can use your smartphone's camera to take a photo of the front and back of your driver's license, and presto, your new checking, savings or credit card account is open. Here's a look at other financial products and services personal financial experts think we'll be using in the future. Within 10 years. "The economic payments system will begin to 'know us,' either through biometrics, optical sensor or facial recognition," says Joshua Siegel, managing principal of StoneCastle Partners, a New York-based asset management firm that invests in banks. That's already happening to some extent with smartphones –- the new Apple (AAPL) iPhone 5S, for example, uses fingerprint scanning to unlock the phone. Meanwhile, some fi

• [By James E. Brumley]

  Anybody who was lucky enough to get into a Recon Technology, Ltd. (NASDAQ:RCON) position before October 7th, then congratulations - you're up big-time. Now get out. Instead, a better use of that capital is Mitek Systems, Inc. (NASDAQ:MITK). While RCON is overbought and ripe for a pullback, MITK is itching to stage a breakout.

Best Managed Healthcare Companies To Watch For 2014: Gamestop Corporation (GME)

GameStop Corp. operates as a retailer of video game products and personal computer (PC) entertainment software. It sells new and used video game hardware; video game software; used video game products; and video game accessories, which primarily consist of controllers, memory cards, and other add-ons, as well as strategy guides and trading cards. The company also offers PC entertainment and other software across various genres, including sports, action, strategy, adventure/role playing, and simulation, as well as products that relate to the digital category comprising network point cards, prepaid digital and online timecards, and digitally downloadable software. GameStop Corp. sells its products through stores, as well as through its electronic commerce Web sites, including gamestop.com, ebgames.com.au, gamestop.ca, gamestop.it, gamestop.es, gamestop.ie, gamestop.de, and micromania.fr. As of July 12, 2011, its retail network and family of brands included 6,573 company-oper ated stores in 17 countries worldwide. The company also publishes Game Informer, a video game magazine in the United States; and operates the online video gaming Web sites kongregate.com and joltonline.com. GameStop Corp. was founded in 1994 and is based in Grapevine, Texas.

Advisors' Opinion:

• [By Tamara Rutter]

  It has been a tough year for retail stocks. That is, unless we're talking about video game retailer GameStop (NYSE: GME  ) . Shares of GameStop stock have rallied so far this year, with the stock up more than 46% year to date. However, not everyone is optimistic about the stock's future. In fact, GameStop stock is now one of the top 25 most shorted S&P 500 components. Is the bear case accurate or is there more to the GameStop story?

• [By Rick Munarriz]

  In this video, longtime Fool contributor Rick Munarriz takes a look at a few things that investors will be watching as Mr. Softy plays hardball with its new console. It's not just Nintendo and Sony investors who need to pay attention. Microsoft's moves will have implications for GameStop (NYSE: GME  ) and Netflix (NASDAQ: NFLX  ) , too.

• [By Rick Munarriz]

  Investors have cheered on the news, and AMD shares have more than doubled since bottoming out six months ago. Even game retailer GameStop (NYSE: GME  ) has raced to fresh 52-week highs on the hopes that Microsoft and Sony can breathe new life into the fading video game industry.